Cas:350511-12-5 N-(5-bromopyridin-2-yl)-1,3-thiazol-2-amine manufacturer & supplier

Chemical Name:N-(5-bromopyridin-2-yl)-1,3-thiazol-2-amine

CAS.NO:350511-12-5

Synonyms:5-Bromo-N-2-thiazolyl-2-pyridinamine

Molecular Formula:C₈H₆BrN₃S

Molecular Weight:256.12200

HS Code:2934100090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:66.05000

Exact Mass:254.94700

LogP:3.11720

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 5-Bromo-N-2-thiazolyl-2-pyridinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-N-2-thiazolyl-2-pyridinamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-N-2-thiazolyl-2-pyridinamine Use and application,5-Bromo-N-2-thiazolyl-2-pyridinamine technical grade,usp/ep/jp grade.

Related News: In the process of fine chemical industry transfer, intermediates are a very important category, and they are also the main link for China to undertake transfers. N-(5-bromopyridin-2-yl)-1,3-thiazol-2-amine manufacturer In 2004, the National Development and Reform Commission, the former Ministry of Health, and the Ministry of Finance jointly formulated and promulgated the Administrative Measures for the Configuration and Use of Large Medical Equipment. This method uses X-ray electronic computer tomography (CT) devices and medical magnetic resonance imaging equipment, digital subtraction angiography X-ray machines of 800 mA or more as the management products of large-scale medical equipment, Purchase and use need to be reported to the provincial health administrative department for approval before approval. However, in recent years, with the comprehensive coverage of medical insurance, such basic medical facilities are being widely popularized, and the relevant implementation rules have directly linked the number of equipment to the number of doctors. Therefore, as the demand for imaging equipment continues to increase, it will have a greater boosting effect on the upstream contrast agent and its raw material market. N-(5-bromopyridin-2-yl)-1,3-thiazol-2-amine supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma��s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution. N-(5-bromopyridin-2-yl)-1,3-thiazol-2-amine vendor China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug. N-(5-bromopyridin-2-yl)-1,3-thiazol-2-amine factory China has granted conditional approval to its first self-developed treatment for Alzheimer��s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.